Skip to content

Public FDA record

Z-1613-2016: NovaPACS Diagnostic Viewer versions 8.3.7, 8.4.2, 8.4.3, and 8.4.4. Novarad Corporation

Recall record Z-1613-2016 for Novarad Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1613-2016
Company in FDA record
Novarad Corporation
FDA classification date
May 6, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The SUV values that are being calculated in the PET/CT fusion tool are incorrect.

Source facts

Action
Consignees were notified on 11/16/15 via letter to contact Novarad Technical Support to arrange for an upgrade to a corrected version of NovaPACS software.
Initiated
2015-11-16
Root cause
Software design
Terminated
2016-08-17
Distribution
Nationwide. 3 Canadian and 33 foreign consignees. No VA/gov/military.
Recall number
Z-1613-2016
Recall status
Terminated
CDRH record ID
145814
FDA classified
2016-05-06
Recall event number
73977

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗